comparemela.com

Latest Breaking News On - Merck cie - Page 1 : comparemela.com

CEO Ulf Jungnelius to leave Isofol Medical on June 1, 2023

/PRNewswire/ Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL), announced today that Chief Executive Officer Dr. Ulf Jungnelius M.D. and Isofol s Board of.

Germany
Sweden
Stockholm
Schaffhausen
Bayern
Gothenburg
Vastra-gotalands-lan
Ulf-jungnelius
Merck-cie
Nasdaq-stockholm
Chief-executive-officer

CEO Ulf Jungnelius to leave Isofol Medical on June 1, 2023

CEO Ulf Jungnelius to leave Isofol Medical on June 1, 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Germany
Sweden
Stockholm
Schaffhausen
Bayern
Gothenburg
Vastra-gotalands-lan
Ulf-jungnelius
Merck-cie
Nasdaq-stockholm
Chief-executive-officer

Final data from the AGENT study confirms topline results

Final data from the AGENT study confirms topline results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Germany
Australia
Japan
Stockholm
Sweden
Gothenburg
Vastra-gotalands-lan
Schaffhausen
Bayern
Canada
Ulf-jungnelius
Merck-cie

Isofol appoints nomination committee ahead of the Annual General Meeting 2023

/PRNewswire/ Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), ("Isofol" or the "Company"), announced today that the members of the nomination committee.

Germany
Sweden
Stockholm
Schaffhausen
Bayern
Gothenburg
Vastra-gotalands-lan
Lars-lind
Ulf-jungnelius
Merck-cie
Hans-enocsson
Arvid-wallgrens-backe

Invitation to presentation of Isofol's report for the third quarter of 2022

/PRNewswire/ Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL) ("Isofol"), will publish the company s results for the third quarter of 2022 on Friday,.

Germany
Sweden
Stockholm
Schaffhausen
Bayern
United-kingdom
Gothenburg
Vastra-gotalands-lan
Ulf-jungnelius
Merck-cie
Nasdaq-stockholm

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.